phrykt

Inogen Inc (INGN): who owns it and who trades it

As of Nov 16, 2026, INGN insiders reported 2 open-market sales worth $143K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Boyer Jennifer M Yi (Vice president), with $143K. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Inogen

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns INGN

127 funds and institutions reported INGN shares worth $125M at the end of Q2 2026, about 72% of the company. The largest holder is BlackRock, Inc. with 6.5%.

Funds and institutions (13F) 72%Everyone else 28%

10 largest owners, by share of the company

BlackRock, Inc.6.5%
Acadian Asset Management LLC4.1%
Armistice Capital, LLC4.0%
Vanguard Capital Management LLC3.8%
Ameriprise Financial Inc3.6%
AQR Capital Management LLC3.5%
DAFNA Capital Management LLC3.1%
Arrowstreet Capital, Limited Partnership2.7%
Morgan Stanley2.4%
Geode Capital Management, LLC2.4%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.1.75M6.46%$11.3M+6%
Acadian Asset Management LLC1.10M4.05%$7.1M+1%
Armistice Capital, LLC1.10M4.05%$7.1M-9%
Vanguard Capital Management LLC1.04M3.84%$6.7M+0%
Ameriprise Financial Inc983,0283.63%$6.3M+14%
AQR Capital Management LLC937,3343.46%$6M+119%
DAFNA Capital Management LLC845,1793.12%$5.5MNo change
Arrowstreet Capital, Limited Partnership743,2522.75%$4.8M+27%
Morgan Stanley646,2762.39%$4.2M+19%
Geode Capital Management, LLC641,5212.37%$4.1M+5%
State Street Corp591,9432.19%$3.8M+3%
Federated Hermes, Inc.534,9361.98%$3.5M+4%
Dimensional Fund Advisors LP488,6451.80%$3.2M-4%
JPMorgan Chase & Co480,3081.77%$3.3M–
Renaissance Technologies LLC476,7001.76%$3.1M-0%
Goldman Sachs Group Inc435,5851.61%$2.8M-25%
CSM Advisors, LLC413,4251.53%$2.7M-0%
ExodusPoint Capital Management, LP393,8031.45%$2.5M+19%
Jacobs Levy Equity Management, Inc388,7881.44%$2.5M+31%
Prudential Financial Inc328,9701.22%$2.1M-11%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, INGN insiders reported $0 of open-market purchases and $143K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$143K
2 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Jul 1, 2026
Filed Jul 6, 2026

Purchases and sales by month

$72.2K$72.2KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jul 1, 2026Boyer Jennifer M YiVice presidentSale10,938$6.60$72.2KForm 4
May 29, 2026Boyer Jennifer M YiVice presidentSale10,770$6.53$70.3KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Boyer Jennifer M YiEVP Entrprs Enblmnt, Ch HR Off–$143KJul 1, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

INGN short interest

Moderate short interest. 5.4% of INGN shares are sold short: about 1 share in 19. Over the last 12 reports the number of shares short went up 75%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 1.40M INGN shares were sold short, 5.4% of the shares outstanding, down 8.3% from the report before. At the average daily volume of 243,734 shares, buying them all back would take about 5.8 trading days (days to cover).

Shares short, % of all shares

5.40%May 15Oct 306.19%

Days to cover

5.8May 15Oct 307.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.40M5.40%-8%243,7345.8
Oct 15, 20261.53M5.77%+4%373,5554.1
Sep 30, 20261.47M5.55%+8%404,1313.6
Sep 15, 20261.37M5.15%-7%265,6735.1
Aug 31, 20261.46M5.51%+2%225,2096.5
Aug 14, 20261.44M5.42%+14%293,5044.9
Jul 31, 20261.26M4.65%+19%200,6146.3
Jul 15, 20261.05M3.89%+3%201,0145.2
Jun 30, 20261.03M3.79%+15%278,2633.7
Jun 15, 2026892,6043.30%-5%385,6692.3
May 29, 2026943,4893.48%+18%339,0612.8
May 15, 2026802,0832.96%-24%386,6792.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Inogen company events

Inogen filed 10 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026LeadershipThe Board of Directors of the Company appointed Andrew P. Reding, the Company's current Chief Operating Officer, to serve as President and Chief Executive Officer of the Company, effective October 30, 2026. Filing
  2. Sep 30, 2026AgreementInogen, Inc. entered into an Asset Purchase Agreement with Rotech Healthcare Inc., pursuant to which the Company agreed to sell to the Buyer substantially all of the assets used or held for use solely in the operation of the Company’s United States oxygen rental business, including specified… Filing
  3. Aug 6, 2026ResultsReleased financial results. Filing
  4. Jul 1, 2026LeadershipThe Board of Directors of Inogen, Inc. appointed Andrew (Andy) Reding to serve as Executive Vice President, Chief Operating Officer of the Company, effective July 6, 2026. Filing
  5. Jun 11, 2026LeadershipAt the annual meeting of stockholders of Inogen, Inc., the Company’s stockholders approved the adoption of the Company’s Amended and Restated 2023 Equity Incentive Plan, which was previously adopted by the Company’s board of directors. Filing
  6. May 7, 2026ResultsReleased financial results. Filing
  7. Apr 6, 2026LeadershipThe Board appointed Vafa Jamali as a Class I director, effective as of the Effective Date, to serve a term expiring at the Company’s 2027 annual meeting of stockholders or until his successor is duly elected and qualified. Filing
  8. Mar 30, 2026LeadershipThe Board of Directors of Inogen, Inc. appointed Jason Richardson to serve as Executive Vice President, Chief Financial Officer and Treasurer of the Company, effective April 6, 2026. Filing
  9. Feb 24, 2026ResultsReleased financial results. Filing
  10. Jan 12, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Inogen financials

Famous investors that hold INGN

4 of the 50 well-known investors we track reported holding INGN in their latest 13F filing. The largest position is Jim Simons's, worth $2.5M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 2026479,000$2.5M0.0%+0%
Ken Griffin · Citadel AdvisorsQ3 2026323,009$1.7M0.0%New
Steve Cohen · Point72 Asset ManagementQ3 2026227,336$1.2M0.0%+33%
Israel Englander · Millennium ManagementQ3 202630,424$160K0.0%+29%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Inogen Inc (INGN) stock

Who owns the most INGN stock?

The largest reported owner of Inogen Inc (INGN) is BlackRock, Inc., with 6.5% of the company. In total, 127 funds and institutions reported holding INGN at the end of Q2 2026, together about 72% of the shares. See the largest owners.

Are INGN insiders buying or selling?

In the last 12 months, INGN insiders reported no open-market purchases and 2 sales worth $143K. The latest trade was on Jul 1, 2026. See every trade.

What is the short interest in INGN?

As of Oct 30, 2026, 1.40M INGN shares were sold short, 5.4% of the shares outstanding, down 8.3% from the report before. At the average daily volume of 243,734 shares, buying them all back would take about 5.8 trading days (days to cover). See the history.

Which famous investors hold INGN?

4 of the 50 well-known investors we track reported INGN in their latest 13F filing, including Jim Simons, Ken Griffin, Steve Cohen. The largest position is worth $2.5M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.